Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
5 hedge funds and large institutions have $3.17M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
1,551% more capital invested
Capital invested by funds: $192K → $3.17M (+$2.98M)
400% more funds holding
Funds holding: 1 → 5 (+4)
19.56% more ownership
Funds ownership: 1.34% → 20.91% (+20%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
+$1.06M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$430K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$187K |
| 4 |
Jane Street
New York
|
+$173K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$28K |
Top Sellers
PILL Hedge Fund Activity: Q4 2019 in Review
5 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q4 2019, worth a combined $3.17M — up 1,551% from $192K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new PILL positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was IMC Chicago, opening a new position worth an estimated $1.06M.
- 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q4 2019, up from 1 in Q3 2019.
- Funds reported $3.17M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q4 2019, up 1,551% quarter-over-quarter.
- 4 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q4 2019 and 0 closed out, a net change of +4 holders.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q4 2019 was IMC Chicago, an estimated $1.06M added.
Based on aggregated 13F filings for Q4 2019.